SCHEMBL30360618

SCHEMBL30360618

CC(C)N1C2CCC1CN(c1ccc(-c3cnc4cc(-c5ccc(S(C)(=O)=O)cc5F)n(C)c4c3)cc1)C2

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PRKDC P78527 1/20 0.37
▸ GPR119 Q8TDV5 7/20 0.35
▸ GABRA2 P47869 4/20 0.34
▸ FGFR1 P11362 2/20 0.34
▸ MAP4K1 Q92918 1/20 0.34
▸ ACVR1 Q04771 1/20 0.34
▸ PTGS1 P23219 2/20 0.33
▸ PTGS2 P35354 2/20 0.33
▸ FLT1 P17948 1/20 0.33
▸ FGFR2 P21802 1/20 0.33
▸ FGFR4 P22455 1/20 0.33
▸ FGFR3 P22607 1/20 0.33
▸ FLT4 P35916 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ FRS2 Q8WU20 1/20 0.33
▸ MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26516738 1.00 PRKDC (0.37) PRKDCGPR119GABRA2FGFR1MAP4K1
SCHEMBL26516667 0.89 MAP4K1 (0.39) PRKDCGPR119MAP4K1PTGS2
SCHEMBL26516732 0.87 MAP4K1 (0.41) PRKDCMAP4K1ACVR1PTGS1PTGS2
SCHEMBL30360607 0.87 MAP4K1 (0.41) PRKDCMAP4K1ACVR1PTGS1PTGS2
SCHEMBL26516742 0.86 MAP4K1 (0.40) PRKDCGPR119GABRA2MAP4K1ACVR1
SCHEMBL30360625 0.84 HRH3 (0.41) PRKDCGPR119GABRA2FGFR1MAP4K1
SCHEMBL26516735 0.84 HRH3 (0.41) PRKDCGPR119GABRA2FGFR1MAP4K1
SCHEMBL26516688 0.80 MAP4K1 (0.39) GPR119MAP4K1ACVR1PTGS1PTGS2
SCHEMBL26516685 0.80 MAP4K1 (0.39) GPR119MAP4K1ACVR1PTGS1PTGS2
SCHEMBL30360601 0.75 MAP4K1 (0.47) GPR119MAP4K1ACVR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4200015-A1 SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9 Bristol-Myers Squibb Company (US) 2023-06-28 — — EP claimed
CN-115956077-A Substituted heteroaryl compounds as TLR9 inhibitors 百时美施贵宝公司 2023-04-11 — — CN claimed
Send feedback